| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 191.156 | 211.167 | 228.139 | 205.009 | 191.622 | 196.615 | 209.007 | 245.226 | 265.698 | 286.736 |
| Total Income - EUR | 191.164 | 211.171 | 228.142 | 205.021 | 191.931 | 196.640 | 209.047 | 245.243 | 265.706 | 286.757 |
| Total Expenses - EUR | 203.691 | 220.357 | 223.709 | 173.485 | 194.001 | 182.567 | 214.281 | 227.878 | 232.159 | 264.927 |
| Gross Profit/Loss - EUR | -12.527 | -9.185 | 4.433 | 31.536 | -2.070 | 14.073 | -5.233 | 17.365 | 33.546 | 21.830 |
| Net Profit/Loss - EUR | -12.527 | -9.385 | 2.227 | 29.347 | -4.075 | 12.017 | -7.324 | 14.913 | 30.906 | 13.400 |
| Employees | 17 | 15 | 14 | 13 | 10 | 10 | 11 | 12 | 7 | 7 |
Check the financial reports for the company - Amicus Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 12.145 | 8.955 | 2.459 | 3.511 | 2.795 | 3.157 | 2.795 | 61.476 | 52.301 | 42.693 |
| Current Assets | 19.742 | 16.391 | 24.521 | 47.347 | 44.418 | 53.599 | 48.739 | 31.691 | 51.445 | 82.176 |
| Inventories | 889 | 1.055 | 96 | 1.105 | 770 | 1.216 | 971 | 1.066 | 0 | 0 |
| Receivables | 13.642 | 11.413 | 16.649 | 19.775 | 17.771 | 16.915 | 18.567 | 21.136 | 27.159 | 30.892 |
| Cash | 5.211 | 3.922 | 7.775 | 26.467 | 25.876 | 35.468 | 29.201 | 9.488 | 24.286 | 51.284 |
| Shareholders Funds | 6.660 | -2.793 | -519 | 28.838 | 24.204 | 35.762 | 27.646 | 42.523 | 73.301 | 13.453 |
| Social Capital | 49 | 49 | 48 | 47 | 46 | 45 | 44 | 45 | 44 | 44 |
| Debts | 25.308 | 28.138 | 27.499 | 22.245 | 23.053 | 21.482 | 24.633 | 52.021 | 31.512 | 119.572 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Amicus Med S.r.l.